Robert A. Winn Career Development Award (Winn CDA)
The Robert A. Winn Diversity in Clinical Trials: Career Development Award (Winn CDA) is part of a broader initiative, the Robert A. Winn Diversity in Clinical Trials Award Program (Winn Awards), which seeks to increase diversity in clinical trials and transform the clinical research landscape.
The Winn CDA is a 2-year program designed to support the career development of early-stage investigator physicians underrepresented in medicine, and physicians who have a demonstrated commitment to increasing diversity in clinical research, to become independent clinical trial investigators who are engaged in advancing health equity through their research and mentoring.
- To train and develop 308 new clinical investigators dedicated to increasing diversity in clinical trials (~60/year)
- Provide opportunities to support ongoing career and leadership development in clinical research
$240k over 2 years ($120K/year for 2 years); requires at least 40% of the scholar’s time (Note: Awards will be given to organizations, not to individuals.)
It is expected that the award will cover a percentage of the scholar’s salary to garner 40% of his/her time. Additionally, funds can be used toward a portion of a research assistant/coordinator/patient navigator salary; activities such travel and registration for presentations, publications, and other trainings for career development; and a limited amount for biostatistical support, and patient recruitment/retention activities. Funds should not otherwise be used or any study activities. If funds are used for indirect costs, the amount cannot exceed $10,000 per year.
Each scholar must be mentored by an experienced clinical investigator at an established clinical trial site and participate substantively in the mentor's active clinical trial (it is not expected that scholars will have their own clinical trials).
The goal of the Winn CDA is to develop a new generation of clinical trialists. The Community-Oriented Clinical Trialist (COCT) curriculum is designed to develop and train a new generation of first-rate clinical trialists with the additional knowledge, skills, and competencies to effectively engage with communities to foster active community participation in clinical research.
The COCT training will launch with a 4 ½-day intensive educational workshop on clinical trial research methods. Winn CDA has partnered with the American Association of Cancer Research (AACR) to develop and deliver the Winn-AACR Design and Implementation of Clinical Trials (DICT) Workshop. This 4 ½-day training, which will introduce Scholars to foundational knowledge in state-of-the-art clinical trial design, development, implementation, and community engagement. Over the course of the 2-yr program, Scholars will participate in a fully elaborated COCT curriculum, featuring weekly or biweekly lectures by distinguished faculty, which will build and expand upon concepts presented during the Winn-AACR DICT Workshop, providing a comprehensive approach to presenting community outreach and engagement methods, skills, and strategies.
Please note: This Workshop is a required element of the Winn CDA Program. 2024 Winn-AACR DICT Workshop dates to be announced soon (Nov or Dec 2024).
Please click here for more information about the 2023 Winn-AACR Design and Implementation of Clinical Trials Workshop, an essential program element to the Winn CDA.
Robert A. Winn Clinical Investigator Pathway Program (Winn CIPP) Mentoring
Each scholar will serve as a mentor to an URiM medical student during the first summer of their program. 308 URiM medical students (60/year) will participate in a 6- to 8-week summer immersion program working in community-based clinical research organizations to learn the basics of clinical trials and community outreach, education, and engagement efforts.
Clinical Research Focus Areas
Cancer (Hematology and Oncology), Cardiovascular Disease and Immunologic Disorders
Scholars may be practicing at urban centers / known clinical trial sites, and rural and/or trial naïve sites.
An annual in-person event in the Fall 2025 and 2026 will bring key stakeholder groups together to inspire, educate, amplify and celebrate. Scholars will present their investigator-initiated clinical trial protocols in their second program year.